Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR-52.4%
5Y CAGR-19.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-52.4%/yr
vs +212.7%/yr prior
5Y CAGR
-19.5%/yr
Recent deceleration
Acceleration
-265.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $12.39M | -55.2% |
| 2024 | $27.65M | +42.5% |
| 2023 | $19.40M | -83.1% |
| 2022 | $114.52M | -38.3% |
| 2021 | $185.62M | +407.1% |
| 2020 | $36.61M | +6052.4% |
| 2019 | $595000.00 | -50.3% |
| 2018 | $1.20M | - |